Designed around the way
your specialty works.
Case → specimen part → tissue block → slide → stain/image → signed report and addenda.
Accession surgery/biopsy/cytology material with anatomical site, laterality, orientation, collection/fixation times and clinical question.
Grossing records dimensions, margins, photographs, cassette mapping and processing; histology tracks recuts, special stains and immunohistochemistry.
Pathologists use structured organ-specific reports with morphology, grade, invasion, margins, nodes and relevant biomarkers.
Support consultations, multidisciplinary review, molecular testing, archival retrieval, slide loans, report amendments and digital-slide review.
Diagnosis coverage and clinical records
Benign/inflammatory conditions, dysplasia and malignant neoplasms by anatomical site and histological subtype. Separate pathological diagnosis from clinical staging; record grading/staging system and edition, specimen adequacy and uncertainty.
Measurements that give the record meaning
| Measurement | Units / representation | Clinical context |
|---|---|---|
| Specimen/tumour dimensions | mm or cm | Orientation, gross versus microscopic source |
| Margin distance | mm | Named margin, invasive/in-situ distinction |
| Lymph nodes | counts | Examined versus involved, station and deposits |
| Mitotic activity | count per defined area | Area in mm² and method |
| Biomarker expression | %; score; categorical result | Clone/platform, tissue block and scoring system |
| Fixation/cold ischaemia intervals | minutes or hours | Actual collection and fixation timestamps |
| Digital-slide resolution | µm/pixel | Scanner, objective, focus QC and image identifier |
Equipment and integration plans
- Barcode printers/readers, tissue processors, stainers, slide scanners and molecular platforms → tracked production events and reports where interfaces exist.
- Whole-slide images stay in a suitable archive/viewer with specimen/block/slide linkage; DICOM WSI or vendor format/export must be checked per scanner. PDF alone loses searchable diagnostic structure.
Connections require an approved interface and testing against the installed manufacturer, model and software. Listed equipment is a candidate integration target.
Explore equipment & roboticsReporting and meaningful outcomes
Accession-to-report time by case complexity; lost/mislabelled specimen incidents; addenda/amendment rates; pending ancillary studies.
Development scope and clinical validation
Initial scope
Specimen lineage, grossing, slide tracking and licensed structured reporting.
Advanced scope
Digital pathology, biomarker/molecular imports and validated AI decision support with pathologist sign-off.
Example acceptance scenarios
- Every slide must resolve to one block, specimen and patient; a re-labelled slide requires audited correction.
- Amended tumour staging or margin status must notify the treating team and retain original signed content.
Research foundations
- CAP current cancer protocols ↗
- CAP cancer protocol FAQs ↗
- WHO laboratory quality management handbook (2011) ↗
Research snapshot: 23 September 2026. References inform the proposed design; they do not certify FertPro or establish device compatibility. Diagnosis lists and measurement groups are not treatment protocols.